{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:42:58Z","timestamp":1791726178647,"version":"4.3.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s42000-024-00586-3","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T16:04:36Z","timestamp":1723046676000},"page":"517-526","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Fibroblast growth-factor 23-Klotho axis is associated with systemic inflammation and myokine profile in children with chronic kidney disease"],"prefix":"10.1007","volume":"23","author":[{"given":"Vasiliki","family":"Karava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Kondou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Dotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Christoforidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Taparkou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Farmaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikoleta","family":"Printza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,7]]},"reference":[{"key":"586_CR1","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.1007\/s00467-021-04936-w","volume":"36","author":"V Karava","year":"2020","unstructured":"Karava V, Dotis J, Christoforidis A, Kondou A, Printza N (2020) Muscle-bone axis in children with chronic kidney disease: current knowledge and future perspectives. Pediatr Nephrol 36:3813\u20133327","journal-title":"Pediatr Nephrol"},{"key":"586_CR2","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/sj.ki.5001532","volume":"70","author":"DF Sun","year":"2006","unstructured":"Sun DF, Chen Y, Rabkin R (2006) Work-induced changes in skeletal muscle IGF-1 and myostatin gene expression in uremia. Kidney Int 70:453\u2013459","journal-title":"Kidney Int"},{"key":"586_CR3","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1093\/ndt\/gfaa129","volume":"36","author":"S Bataille","year":"2021","unstructured":"Bataille S, Chauveau P, Fouque D, Aparicio M, Koppe L (2021) Myostatin and muscle atrophy during chronic kidney disease. Nephrol Dial Transpl 36:1986\u20131993","journal-title":"Nephrol Dial Transpl"},{"key":"586_CR4","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1007\/s00467-021-04918-y","volume":"36","author":"V Karava","year":"2021","unstructured":"Karava V, Dotis J, Christoforidis A, Liakopoulos V, Kondou A, Tsigaras G, Tsioni K, Kollios K, Printza N (2021) Association between insulin growth factor-1, bone mineral density, and frailty phenotype in children with chronic kidney disease. Pediatr Nephrol 36:1861\u20131870","journal-title":"Pediatr Nephrol"},{"key":"586_CR5","first-page":"1414","volume":"9","author":"V Karava","year":"2022","unstructured":"Karava V, Goutou S, Dotis J, Kondou A, Charela E, Dadoudi O, Eleftheriadis T, Stefanidis I, Printza N (2022) Fatigue and quality of life in children with chronic kidney disease. Child (Basel) 9:1414","journal-title":"Child (Basel)"},{"key":"586_CR6","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1007\/s00467-020-04846-3","volume":"36","author":"K Meza","year":"2021","unstructured":"Meza K, Biswas S, Zhu YS, Gajjar A, Perelstein E, Kumar J, Akchurin O (2021) Tumor necrosis factor-alpha is associated with mineral bone disorder and growth impairment in children with chronic kidney disease. Pediatr Nephrol 36:1579\u20131587","journal-title":"Pediatr Nephrol"},{"key":"586_CR7","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1007\/s10157-022-02238-5","volume":"26","author":"N Yamamura-Miyazaki","year":"2022","unstructured":"Yamamura-Miyazaki N, Michigami T, Ozono K, Yamamoto K, Hasuike Y (2022) Factors associated with 1-year changes in serum fibroblast growth factor 23 levels in pediatric patients with chronic kidney disease. Clin Exp Nephrol 26:1014\u20131021","journal-title":"Clin Exp Nephrol"},{"key":"586_CR8","doi-asserted-by":"publisher","first-page":"100408","DOI":"10.1016\/j.xkme.2022.100408","volume":"4","author":"S Yamada","year":"2022","unstructured":"Yamada S, Arase H, Yoshida H, Kitamura H, Tokumoto M, Taniguchi M, Hirakata H, Tsuruya K, Nakano T, Kitazono T (2022) Malnutrition-inflammation Complex Syndrome and Bone fractures and Cardiovascular Disease events in patients undergoing hemodialysis: the Q-Cohort study. Kidney Med 4:100408","journal-title":"Kidney Med"},{"key":"586_CR9","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s10157-022-02216-x","volume":"26","author":"S Yamada","year":"2022","unstructured":"Yamada S, Tsuruya K, Kitazono T, Nakano T (2022) Emerging cross-talks between chronic kidney disease-mineral and bone disorder (CKD-MBD) and malnutrition-inflammation complex syndrome (MICS) in patients receiving dialysis. Clin Exp Nephrol 26:613\u2013629","journal-title":"Clin Exp Nephrol"},{"key":"586_CR10","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.bbagen.2009.02.005","volume":"1790","author":"M Kuro-o","year":"2009","unstructured":"Kuro-o M (2009) Klotho and aging. Biochim Biophys Acta 1790:1049\u20131058","journal-title":"Biochim Biophys Acta"},{"key":"586_CR11","doi-asserted-by":"publisher","first-page":"931331","DOI":"10.3389\/fragi.2022.931331","volume":"3","author":"GJ Prud\u2019homme","year":"2022","unstructured":"Prud\u2019homme GJ, Kurt M, Wang Q (2022) Pathobiology of the Klotho Antiaging Protein and therapeutic considerations. Front Aging 3:931331","journal-title":"Front Aging"},{"key":"586_CR12","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s00424-021-02561-y","volume":"473","author":"F Ewendt","year":"2021","unstructured":"Ewendt F, Feger M, F\u00f6ller M (2021) Myostatin regulates the production of fibroblast growth factor 23 (FGF23) in UMR106 osteoblast-like cells. Pflugers Arch 473:969\u2013976","journal-title":"Pflugers Arch"},{"key":"586_CR13","doi-asserted-by":"publisher","first-page":"5804","DOI":"10.1073\/pnas.1800160115","volume":"115","author":"L B\u00e4r","year":"2018","unstructured":"B\u00e4r L, Feger M, Fajol A, Klotz LO, Zeng S, Lang F, Hocher B, F\u00f6ller M (2018) Insulin suppresses the production of fibroblast growth factor 23 (FGF23). Proc Natl Acad Sci U S A 115:5804\u20135809","journal-title":"Proc Natl Acad Sci U S A"},{"key":"586_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/bs.vh.2016.02.009","volume":"101","author":"T Rubinek","year":"2016","unstructured":"Rubinek T, Modan-Moses D (2016) Klotho and the growth Hormone\/Insulin-Like Growth factor 1 Axis: Novel insights into Complex interactions. Vitam Horm 101:85\u2013118","journal-title":"Vitam Horm"},{"key":"586_CR15","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.ajpath.2023.01.009","volume":"193","author":"Y Ohsawa","year":"2023","unstructured":"Ohsawa Y, Ohtsubo H, Munekane A, Ohkubo K, Murakami T, Fujino M, Nishimatsu SI, Hagiwara H, Nishimura H, Kaneko R, Suzuki T, Tatsumi R, Mizunoya W, Hinohara A, Fukunaga M, Sunada Y (2023) Circulating \u03b1-Klotho counteracts transforming growth Factor-\u03b2-Induced Sarcopenia. Am J Pathol 193:591\u2013607","journal-title":"Am J Pathol"},{"key":"586_CR16","doi-asserted-by":"publisher","first-page":"e107174","DOI":"10.1371\/journal.pone.0107174","volume":"9","author":"I Wolf","year":"2014","unstructured":"Wolf I, Shahmoon S, Ben Ami M, Levy-Shraga Y, Mazor-Aronovitch K, Pinhas-Hamiel O, Yeshayahu Y, Hemi R, Kanety H, Rubinek T, Modan-Moses D (2014) Association between decreased klotho blood levels and organic growth hormone deficiency in children with growth impairment. PLoS ONE 9:e107174","journal-title":"PLoS ONE"},{"key":"586_CR17","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1007\/s00467-021-05097-6","volume":"36","author":"D Haffner","year":"2021","unstructured":"Haffner D, Grund A, Leifheit-Nestler M (2021) Renal effects of growth hormone in health and in kidney disease. Pediatr Nephrol 36:2511\u20132530","journal-title":"Pediatr Nephrol"},{"key":"586_CR18","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Mu\u00f1oz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629\u2013637","journal-title":"J Am Soc Nephrol"},{"key":"586_CR19","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s00467-023-06234-z","volume":"39","author":"V Karava","year":"2004","unstructured":"Karava V, Kondou A, Dotis J, Taparkou A, Farmaki E, Kollios K, Printza N (2004) Exploring systemic inflammation in children with chronic kidney disease: correlates of interleukin 6. Pediatr Nephrol 39:1567\u20131576","journal-title":"Pediatr Nephrol"},{"key":"586_CR20","doi-asserted-by":"publisher","first-page":"7344","DOI":"10.3390\/ijerph18147344","volume":"18","author":"SJ Choi","year":"2021","unstructured":"Choi SJ, Lee MS, Kang DH, Ko GJ, Lim HS, Yu BC, Park MY, Kim JK, Kim CH, Hwang SD, Kim JC, Won CW, An WS (2021) Myostatin\/Appendicular Skeletal Muscle Mass (ASM) ratio, not myostatin, is Associated with Low Handgrip Strength in Community-Dwelling Older Women. Int J Environ Res Public Healt 18:7344","journal-title":"Int J Environ Res Public Healt"},{"key":"586_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/ki.2015.290","volume":"89","author":"V David","year":"2016","unstructured":"David V, Martin A, Isakova T, Spaulding C, Qi L, Ramirez V, Zumbrennen-Bullough KB, Sun CC, Lin HY, Babitt JL, Wolf M (2016) Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production. Kidney Int 89:135\u2013146","journal-title":"Kidney Int"},{"key":"586_CR22","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.kint.2019.04.009","volume":"96","author":"D Egli-Spichtig","year":"2019","unstructured":"Egli-Spichtig D, Imenez Silva PH, Glaudemans B, Gehring N, Bettoni C, Zhang MYH, Pastor-Arroyo EM, Sch\u00f6nenberger D, Rajski M, Hoogewijs D, Knauf F, Misselwitz B, Frey-Wagner I, Rogler G, Ackermann D, Ponte B, Pruijm M, Leichtle A, Fiedler GM, Bochud M, Ballotta V, Hofmann S, Perwad F, F\u00f6ller M, Lang F, Wenger RH, Frew I, Wagner CA (2019) Tumor necrosis factor stimulates fibroblast growth factor 23 levels in chronic kidney disease and non-renal inflammation. Kidney Int 96:890\u2013905","journal-title":"Kidney Int"},{"key":"586_CR23","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.kint.2018.02.026","volume":"94","author":"K Durlacher-Betzer","year":"2018","unstructured":"Durlacher-Betzer K, Hassan A, Levi R, Axelrod J, Silver J, Naveh-Many T (2018) Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease. Kidney Int 94:315\u2013325","journal-title":"Kidney Int"},{"key":"586_CR24","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.2215\/CJN.13281211","volume":"7","author":"J Munoz Mendoza","year":"2012","unstructured":"Munoz Mendoza J, Isakova T, Ricardo AC, Xie H, Navaneethan SD, Anderson AH, Bazzano LA, Xie D, Kretzler M, Nessel L, Hamm LL, Negrea L, Leonard MB, Raj D, Wolf M, Chronic Renal Insufficiency Cohort (2012) Fibroblast growth factor 23 and inflammation in CKD. Clin J Am Soc Nephrol 7:1155\u20131162","journal-title":"Clin J Am Soc Nephrol"},{"key":"586_CR25","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.2215\/CJN.02420409","volume":"4","author":"JF Navarro-Gonz\u00e1lez","year":"2009","unstructured":"Navarro-Gonz\u00e1lez JF, Mora-Fern\u00e1ndez C, Muros M, Herrera H, Garc\u00eda J (2009) Mineral metabolism and inflammation in chronic kidney Disease patients: a cross-sectional study. Clin J Am Soc Nephrol 4:1646\u20131654","journal-title":"Clin J Am Soc Nephrol"},{"key":"586_CR26","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.2337\/db10-1262","volume":"60","author":"Y Zhao","year":"2011","unstructured":"Zhao Y, Banerjee S, Dey N, LeJeune WS, Sarkar PS, Brobey R, Rosenblatt KP, Tilton RG, Choudhary S (2011) Klotho depletion contributes to increased inflammation in kidney of the db\/db mouse model of diabetes via RelA (serine)536 phosphorylation. Diabetes 60:1907\u20131916","journal-title":"Diabetes"},{"key":"586_CR27","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1681\/ASN.2010101073","volume":"22","author":"JA Moreno","year":"2011","unstructured":"Moreno JA, Izquierdo MC, Sanchez-Ni\u00f1o MD, Su\u00e1rez-Alvarez B, Lopez-Larrea C, Jakubowski A, Blanco J, Ramirez R, Selgas R, Ruiz-Ortega M, Egido J, Ortiz A, Sanz AB (2011) The inflammatory cytokines TWEAK and TNF\u03b1 reduce renal klotho expression through NF\u03baB. J Am Soc Nephrol 22:1315\u20131325","journal-title":"J Am Soc Nephrol"},{"key":"586_CR28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3747\/pdi.2013.00150","volume":"35","author":"HJ Oh","year":"2015","unstructured":"Oh HJ, Nam BY, Lee MJ, Kim CH, Koo HM, Doh FM, Han JH, Kim EJ, Han JS, Park JT, Yoo TH, Kang SW, Han DS, Han SH (2015) Decreased circulating klotho levels in patients undergoing dialysis and relationship to oxidative stress and inflammation. Perit Dial Int 35:43\u201351","journal-title":"Perit Dial Int"},{"key":"586_CR29","doi-asserted-by":"publisher","first-page":"6518","DOI":"10.3390\/jcm11216518","volume":"11","author":"KA Lisowska","year":"2022","unstructured":"Lisowska KA, Storoniak H, Soroczy\u0144ska-Cybula M, Maziewski M, D\u0119bska-\u015alizie\u0144 A (2022) Serum levels of \u03b1-Klotho, inflammation-related cytokines, and Mortality in Hemodialysis patients. J Clin Med 11:6518","journal-title":"J Clin Med"},{"key":"586_CR30","doi-asserted-by":"publisher","first-page":"628","DOI":"10.5603\/EP.a2021.0082","volume":"72","author":"Z Gamrot","year":"2021","unstructured":"Gamrot Z, Adamczyk P, \u015awi\u0119tochowska E, Roszkowska-Bjanid D, Gamrot J, Szczepa\u0144ska M (2021) Tumour necrosis factor alpha (TNF\u03b1) and alpha-klotho (\u03b1KL) in children and adolescents with chronic kidney disease (CKD). Endokrynol Pol 72:628\u2013633","journal-title":"Endokrynol Pol"},{"key":"586_CR31","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.2215\/CJN.10511110","volume":"6","author":"T Miyamoto","year":"2011","unstructured":"Miyamoto T, Carrero JJ, Qureshi AR, Anderstam B, Heimb\u00fcrger O, B\u00e1r\u00e1ny P, Lindholm B, Stenvinkel P (2011) Circulating follistatin in patients with chronic kidney disease: implications for muscle strength, bone mineral density, inflammation, and survival. Clin J Am Soc Nephrol 6:1001\u20131008","journal-title":"Clin J Am Soc Nephrol"},{"key":"586_CR32","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/sj.ki.5001622","volume":"70","author":"RH Mak","year":"2006","unstructured":"Mak RH, Rotwein P (2006) Myostatin and IGF-1 play crucial roles as the dual regulating hormones in the modulation of muscle mass. Kidney Int 70:410\u2013412","journal-title":"Kidney Int"},{"key":"586_CR33","doi-asserted-by":"publisher","first-page":"32084","DOI":"10.1038\/srep32084","volume":"6","author":"Y Enoki","year":"2016","unstructured":"Enoki Y, Watanabe H, Arake R, Sugimoto R, Imafuku T, Tominaga Y, Ishima Y, Kotani S, Nakajima M, Tanaka M, Matsushita K, Fukagawa M, Otagiri M, Maruyama T (2016) Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1. Sci Rep 6:32084","journal-title":"Sci Rep"},{"key":"586_CR34","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1096\/fj.10-176917","volume":"25","author":"L Zhang","year":"2011","unstructured":"Zhang L, Rajan V, Lin E, Hu Z, Han HQ, Zhou X, Song Y, Min H, Wang X, Du J, Mitch WE (2011) Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease. FASEB J 25:1653\u20131663","journal-title":"FASEB J"},{"key":"586_CR35","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.2337\/db08-0245","volume":"58","author":"JJ Wilkes","year":"2009","unstructured":"Wilkes JJ, Lloyd DJ, Gekakis N (2009) Loss-of-function mutation in myostatin reduces tumor necrosis factor alpha production and protects liver against obesity-induced insulin resistance. Diabetes 58:1133\u20131143","journal-title":"Diabetes"},{"key":"586_CR36","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1053\/j.jrn.2022.01.011","volume":"32","author":"E Yasar","year":"2022","unstructured":"Yasar E, Tek NA, Tekbudak MY, Yurtda\u015f G, G\u00fclbahar \u00d6, Uyar G\u00d6, Ural Z, \u00c7elik \u00d6M, Erten Y (2022) The relationship between myostatin, inflammatory markers, and Sarcopenia in patients with chronic kidney disease. J Ren Nutr 32:677\u2013684","journal-title":"J Ren Nutr"},{"key":"586_CR37","doi-asserted-by":"publisher","first-page":"e23818","DOI":"10.1371\/journal.pone.0023818","volume":"6","author":"LT Bish","year":"2011","unstructured":"Bish LT, George I, Maybaum S, Yang J, Chen JM, Sweeney HL (2011) Myostatin is elevated in congenital heart disease and after mechanical unloading. PLoS ONE 6:e23818","journal-title":"PLoS ONE"},{"key":"586_CR38","doi-asserted-by":"publisher","first-page":"469","DOI":"10.5114\/ceji.2020.103422","volume":"45","author":"E Witkowska-S\u0119dek","year":"2020","unstructured":"Witkowska-S\u0119dek E, Pyr\u017cak B (2020) Chronic inflammation and the growth hormone\/insulin-like growth factor-1 axis. Cent J Immunol 45:469\u2013475","journal-title":"Cent J Immunol"},{"key":"586_CR39","doi-asserted-by":"publisher","first-page":"15310","DOI":"10.3390\/ijms232315310","volume":"23","author":"RH Mak","year":"2022","unstructured":"Mak RH, Gunta S, Oliveira EA, Cheung WW (2022) Growth hormone improves adipose tissue Browning and muscle wasting in mice with chronic kidney Disease-Associated Cachexia. Int J Mol Sci 23:15310","journal-title":"Int J Mol Sci"},{"key":"586_CR40","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1210\/en.2011-0159","volume":"152","author":"LA Garcia","year":"2011","unstructured":"Garcia LA, King KK, Ferrini MG, Norris KC, Artaza JN (2011) 1,25(OH)2vitamin D3 stimulates myogenic differentiation by inhibiting cell proliferation and modulating the expression of promyogenic growth factors and myostatin in C2C12 skeletal muscle cells. Endocrinology 152:2976\u20132986","journal-title":"Endocrinology"},{"key":"586_CR41","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/cen.12268","volume":"79","author":"P Ameri","year":"2013","unstructured":"Ameri P, Giusti A, Boschetti M, Murialdo G, Minuto F, Ferone D (2013) Interactions between vitamin D and IGF-I: from physiology to clinical practice. Clin Endocrinol (Oxf) 79:457\u2013463","journal-title":"Clin Endocrinol (Oxf)"},{"key":"586_CR42","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.ekir.2023.04.027","volume":"8","author":"R Elsurer Afsar","year":"2023","unstructured":"Elsurer Afsar R, Afsar B, Ikizler TA (2023) Fibroblast growth factor 23 and muscle wasting: a metabolic point of View. Kidney Int Rep 8:1301\u20131314","journal-title":"Kidney Int Rep"},{"key":"586_CR43","doi-asserted-by":"publisher","first-page":"696942","DOI":"10.3389\/fped.2021.696942","volume":"9","author":"V Karava","year":"2021","unstructured":"Karava V, Christoforidis A, Kondou A, Dotis J, Printza N (2021) Update on the Crosstalk between adipose tissue and Mineral Balance in General Population and chronic kidney disease. Front Pediatr 9:696942","journal-title":"Front Pediatr"},{"key":"586_CR44","first-page":"189","volume":"5","author":"KG Avin","year":"2014","unstructured":"Avin KG, Coen PM, Huang W, Stolz DB, Sowa GA, Dub\u00e9 JJ, Goodpaster BH, O\u2019Doherty RM, Ambrosio F (2014) Skeletal muscle as a regulator of the longevity protein. Klotho Front Physiol 5:189","journal-title":"Klotho Front Physiol"},{"key":"586_CR45","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/jgs.16895","volume":"69","author":"A Jovanovich","year":"2021","unstructured":"Jovanovich A, Ginsberg C, You Z, Katz R, Ambrosius WT, Berlowitz D, Cheung AK, Cho M, Lee AK, Punzi H, Rehman S, Roumie C, Supiano MA, Wright CB, Shlipak M, Ix JH, Chonchol M (2021) FGF23, Frailty, and Falls in SPRINT. J Am Geriatr Soc 69:467\u2013473","journal-title":"J Am Geriatr Soc"},{"key":"586_CR46","doi-asserted-by":"publisher","first-page":"111518","DOI":"10.1016\/j.exger.2021.111518","volume":"154","author":"F Veronesi","year":"2021","unstructured":"Veronesi F, Borsari V, Cherubini A, Fini M (2021) Association of Klotho with physical performance and frailty in middle-aged and older adults: a systematic review. Exp Gerontol 154:111518","journal-title":"Exp Gerontol"},{"key":"586_CR47","doi-asserted-by":"publisher","first-page":"5490","DOI":"10.1210\/jc.2003-030497","volume":"88","author":"W Liu","year":"2003","unstructured":"Liu W, Thomas SG, Asa SL, Gonzalez-Cadavid N, Bhasin S, Ezzat S (2003) Myostatin is a skeletal muscle target of growth hormone anabolic action. J Clin Endocrinol Metab 88:5490\u20135496","journal-title":"J Clin Endocrinol Metab"},{"key":"586_CR48","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/j.metabol.2016.08.004","volume":"65","author":"T Rubinek","year":"2016","unstructured":"Rubinek T, Shahmoon S, Shabtay-Orbach A, Ben Ami M, Levy-Shraga Y, Mazor-Aronovitch K, Yeshayahu Y, Doolman R, Hemi R, Kanety H, Wolf I, Modan-Moses D (2016) Klotho response to treatment with growth hormone and the role of IGF-I as a mediator. Metabolism 65:1597\u20131604","journal-title":"Metabolism"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-024-00586-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-024-00586-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-024-00586-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T08:10:12Z","timestamp":1727424612000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-024-00586-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,7]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["586"],"URL":"https:\/\/doi.org\/10.1007\/s42000-024-00586-3","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,7]]},"assertion":[{"value":"14 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed were in accordance with the ethical standards of the institutional research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Approval was granted by the Ethics Committee of the Faculty of Health Sciences of Aristotle University of Thessaloniki, Greece.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from the parents of all the participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no conflicts of interest that are relevant to the content of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}